These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7797946)

  • 21. Prevalence and molecular characterization of human T cell leukemia virus type 2 in a group of intravenous drug users coinfected with HIV type 1 in Portugal.
    Silva AF; Almeida C; Martins HC; Coutinho R; Leitão E; Silva R; Paixão MT; Pádua E
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):249-55. PubMed ID: 15943566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Seroprevalence and risk factors for human T cell lymphotropic virus type 1 and 2 infection in human immunodeficiency virus-infected patients attending AIDS referral center health units in Londrina and other communities in Paraná, Brazil.
    Morimoto HK; Caterino-De-Araujo A; Morimoto AA; Reiche EM; Ueda LT; Matsuo T; Stegmann JW; Reiche FV
    AIDS Res Hum Retroviruses; 2005 Apr; 21(4):256-62. PubMed ID: 15943567
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An international collaborative study of the effects of coinfection with human T-lymphotropic virus type II on human immunodeficiency virus type 1 disease progression in injection drug users.
    Hershow RC; Galai N; Fukuda K; Graber J; Vlahov D; Rezza G; Klein RS; Des Jarlais DC; Vitek C; Khabbaz R; Freels S; Zuckerman R; Pezzotti P; Kaplan JE
    J Infect Dis; 1996 Aug; 174(2):309-17. PubMed ID: 8699060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acquired ichthyosis in concomitant HIV-1 and HTLV-II infection: a new association with intravenous drug abuse.
    Kaplan MH; Sadick NS; McNutt NS; Talmor M; Coronesi M; Hall WW
    J Am Acad Dermatol; 1993 Nov; 29(5 Pt 1):701-8. PubMed ID: 8227542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human T-cell leukemia virus type II infection among high risk groups and its influence on HIV-1 disease progression.
    Giacomo M; Franco EG; Claudio C; Carlo C; Anna DA; Anna D; Franco F
    Eur J Epidemiol; 1995 Oct; 11(5):527-33. PubMed ID: 8549726
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High rate of human T lymphotropic virus type IIa infection in HIV type 1-infected intravenous drug abusers in Ireland.
    Egan JF; O'Leary B; Lewis MJ; Mulcahy F; Sheehy N; Hasegawa H; Fitzpatrick F; O'Connor JJ; O'Riordan J; Hall WW
    AIDS Res Hum Retroviruses; 1999 May; 15(8):699-705. PubMed ID: 10357465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV-1, HTLV-I, and HTLV-II in a semiurban population in East Gabon.
    Bertherat E; Makuwa M; Renaut A; Nabias R; Georges-Courbot MC
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):430-2. PubMed ID: 9833756
    [No Abstract]   [Full Text] [Related]  

  • 28. HTLV-I and -II in intravenous drug users from Sweden and Denmark.
    Blomberg J; Moestrup T; Frimand J; Hansson BG; Krogsgaard K; Grillner L; Nordenfelt E
    Scand J Infect Dis; 1994; 26(1):23-6. PubMed ID: 8191236
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human retroviruses in Amerindians of Colombia: high prevalence of human T cell lymphotropic virus type II infection among the Tunebo Indians.
    Duenas-Barajas E; Bernal JE; Vaught DR; Nerurkar VR; Sarmiento P; Yanagihara R; Gajdusek DC
    Am J Trop Med Hyg; 1993 Dec; 49(6):657-63. PubMed ID: 8279632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HTLV-1 and HTLV-2 infections in HIV-infected individuals from Santos, Brazil: seroprevalence and risk factors.
    Etzel A; Shibata GY; Rozman M; Jorge ML; Damas CD; Segurado AA
    J Acquir Immune Defic Syndr; 2001 Feb; 26(2):185-90. PubMed ID: 11242188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human T-lymphotropic Virus Co-infections in Adults Infected With Human Immunodeficiency Virus.
    Rossheim AE; Cunningham TD; Troy SB
    Am J Med Sci; 2016 Sep; 352(3):258-60. PubMed ID: 27650229
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of retroviral infections on immune function in African-American intravenous drug users.
    Klimas NG; Page JB; Patarca R; Chitwood D; Morgan R; Fletcher MA
    AIDS; 1993 Mar; 7(3):331-5. PubMed ID: 8471194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Seroprevalence of human T-lymphotropic virus type I or II in sexually transmitted disease clinic patients in the USA.
    Khabbaz RF; Douglas JM; Judson FN; Spiegel RA; St Louis ME; Whittington W; Hartley TM; Lairmore M; Kaplan JE
    J Infect Dis; 1990 Jul; 162(1):241-4. PubMed ID: 2192006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV infection and AIDS risk behaviors among intravenous drug users entering methadone treatment in selected U.S. cities.
    Battjes RJ; Pickens RW; Amsel Z
    J Acquir Immune Defic Syndr (1988); 1991; 4(11):1148-54. PubMed ID: 1753342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seroepidemiology of viral infections among intravenous drug users in northern California.
    Zeldis JB; Jain S; Kuramoto IK; Richards C; Sazama K; Samuels S; Holland PV; Flynn N
    West J Med; 1992 Jan; 156(1):30-5. PubMed ID: 1310362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. No proof of HTLV-I/II in intravenous drug abusers with a high rate of HIV-1 infection in central Thailand.
    Saguanwongse S; Muangpom A; Ruchusatsawat N; Wongcheree S; Warachit P; Miyamura K; Yamazaki S; Honda M
    Microbiol Immunol; 1996; 40(9):639-44. PubMed ID: 8908608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HTLV-I and HTLV-II infections among HIV-1 seropositive patients in Sao Paulo, Brazil.
    de Araujo AC; Casseb JS; Neitzert E; de Souza ML; Mammano F; Del Mistro A; De Rossi A; Chieco-Bianchi L
    Eur J Epidemiol; 1994 Apr; 10(2):165-71. PubMed ID: 7813694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative performances of serologic and molecular assays for detecting human T lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) in patients infected with human immunodeficiency virus type 1 (HIV-1).
    Campos KR; Gonçalves MG; Costa NA; Caterino-de-Araujo A
    Braz J Infect Dis; 2017; 21(3):297-305. PubMed ID: 28343818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematological indices in a cohort of HTLV-I/II and HIV-1 infected intravenous drug users in New York City.
    Brown LS; Chu A; Lee H; Allain JP
    J Natl Med Assoc; 1991 Aug; 83(8):677-9. PubMed ID: 1956078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Retroviral coinfections at a New Orleans HIV outpatient clinic.
    Bessinger R; Beilke M; Kissinger P; Jarrott C; Tabak OF
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jan; 14(1):67-71. PubMed ID: 8989213
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.